510(k) K210452

Creatinine2 by Abbott Ireland Diagnostics Division — Product Code CGX

K210452 is an FDA 510(k) premarket notification submitted by Abbott Ireland Diagnostics Division for the device "Creatinine2". The FDA issued a decision of Substantially Equivalent on Mar 22, 2022. The device falls under product code CGX (Alkaline Picrate, Colorimetry, Creatinine), a Class II device regulated under 21 CFR 862.1225. Abbott Ireland Diagnostics Division has 7 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 22, 2022
Date Received
Feb 16, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Alkaline Picrate, Colorimetry, Creatinine
Device Class
Class II
Regulation Number
862.1225
Review Panel
CH
Submission Type
510(k)

Need the full FDA record for Abbott Ireland Diagnostics Division? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K210452. Report a data issue: hello@regdatalab.com.